Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Leamon Christopher P. Insider active across 2 companies, notably ENDOCYTE INC. Aggregated, 5 reports have been recorded. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Leamon Christopher P is a declarant linked to ENDOCYTE INC, where he was Vice President of Research, and to Fusion Pharmaceuticals Inc., where he was Chief Scientific Officer. His 5 filings span the period from 2016-02-08 to 2024-06-04, and the sampled recent filings show 0 EUR of buys and 0 EUR of sells, with a modal transaction nature of Attribution.